Genmab — Juni 2013
-
Luximia - de forventer at expandere som den ledende indenfor diabetes
-
De skal bruge Lyxumia som primær vækstdriver
-
LixiLan vil repræsentere en gamechanger som først GLP-1 + basal insulin kombination i US
-
De har strong confidence i LixiLan
-
Q&A nu
-
Hunden skal tisse nu
må tage Q&A senere ! lorte liv ! -
link me så tager jeg den
-
for en mand som mig der er færdig med biotek, er jeg imponeret over at 2 ud af mine 3 sidste køb er bava og zeal
-
jeg fik dem aldrig
-
what can you do with a crappy bank
-
get me a banker on the line
-
hvad er royalty på luxima 7-9%?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind